Barcelona, Catalonia, Spain
I’m a scientist and program manager passionate about translating scientific breakthroughs into operationally meaningful outcomes for patients. With a PhD in life sciences and experience managing portfolio- and program-level clinical and translational initiatives, I bring a strong ability to bridge scientific innovation with strategy and execution. My expertise lies in leading cross-functional programs that connect research, clinical, and organizational priorities —from early discovery to applied health solutions. I excel in environments where science meets operations, and where complex ideas are translated with clarity and structure into measurable impact. Skilled in stakeholder management, global team coordination, and strategic partnerships. I thrive in roles that combine scientific rigor and innovation with program governance and delivery, across pharma, biotech, and translational research ecosystems.
At VHIO, I lead portfolio- and program-level management of oncology translational and clinical research initiatives across national and international collaborative networks. I operate as a strategic interface between research groups, clinicians, industry partners, CROs, hospitals, and diverse institutional stakeholders, driving cross-functional coordination, governance, risk and dependency management, and milestone-based execution in multi-partner environments. My role focuses on enabling data-driven decision-making, ensuring regulatory-aligned delivery (GxP, ICH-GCP), and translating scientific programs into clinically, operationally, and strategically viable outcomes within the European research and innovation ecosystem.
At Aptadel Therapeutics, I led cross-functional R&D programs for RNA-based therapies targeting a rare pediatric cancer and other oncologic indications. I coordinated multidisciplinary teams and external partners, ensuring project delivery aligns with strategic goals and regulatory standards (GxP, ICH-GCP, SOPs). My role spanned process improvement, risk management, vendor management, and oversight of governance structures to ensure operational efficiency, providing insights for portfolio planning and decision-making, while supporting translational research and early-stage regulatory submissions.
Prioritization · Process Optimization · Conflict Resolution · Negotiation · Mental Agility · Long Term Thinking
At Ninevah Therapeutics, I led preclinical research and strategy for gene therapy addressing rare pediatric kidney diseases. I oversaw project planning, milestones, and data quality while engaging with KOLs in advanced therapies, regulatory stakeholders, and clinical partners to align scientific objectives with clinical and business priorities. My work included intellectual property development, including filing a European patent as inventor, and data-driven evaluations to support operational efficiency, innovation strategy, and translational application.
Time Management · Adaptability · Resilience · Empathy · Multitasking · Problem Solving